Director at Raymond James (NYSE: RJF) receives RSUs and shares

Rhea-AI Filing Summary

Raymond James Financial director Marlene Debel reported equity awards tied to company stock. She received a grant of 1,303 Restricted Stock Units on February 19, 2026, with each unit representing one share of common stock plus accrued cash in lieu of dividends upon vesting.

The award will vest at the date of the next annual shareholders meeting, but no later than March 15, 2027. On the same date, 1,253 previously granted RSUs vested and were converted into 1,253 shares of common stock at a price of $0.00 per share, bringing her direct holdings to 8,820 common shares and 1,303 RSUs.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DEBEL MARLENE

(Last) (First) (Middle)

880 CARILLON PARKWAY

(Street)

ST. PETERSBURG FL 33716

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RAYMOND JAMES FINANCIAL INC [ RJF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		M		1,253	A	$0(1)	8,820	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/19/2026		A		1,303		(2)	(2)	Common Stock	1,303	$0.0000	2,556	D
Restricted Stock Units	(1)	02/19/2026		M			1,253	(3)	(3)	Common Stock	1,253	$0.0000	1,303	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.

2. The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027.

3. The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.

Remarks:

This Form 4 reports (i) the acquisition by the reporting person of RSUs resulting from an annual grant to the registrant's non-executive directors and (ii) the vesting of RSUs awarded to the reporting person.

	/s/ Marlene Debel by Jonathan J. Doyle as Attorney-in-Fact	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did RJF director Marlene Debel report on this Form 4?

Marlene Debel reported a grant of 1,303 Restricted Stock Units and the vesting and conversion of 1,253 previously granted RSUs into common stock. Each RSU represents one share plus accrued cash in lieu of dividends upon vesting.

How many Raymond James (RJF) RSUs were newly granted to the director?

The director received 1,303 new Restricted Stock Units. These units are scheduled to vest at the next succeeding annual shareholders meeting, but no later than March 15, 2027, and each unit corresponds to one share of common stock upon vesting.

What happened to the previously granted RSUs reported in this RJF Form 4?

A block of 1,253 previously granted Restricted Stock Units vested in accordance with their terms and was converted into 1,253 shares of Raymond James common stock at a price of $0.00 per share, reflecting a derivative exercise or conversion.

What are Marlene Debel’s Raymond James (RJF) share holdings after these transactions?

Following the reported transactions, Marlene Debel directly holds 8,820 shares of Raymond James common stock and 1,303 Restricted Stock Units. The RSUs remain subject to vesting conditions tied to the timing of the company’s next annual shareholders meeting.

How do RJF Restricted Stock Units work for this director award?

Each RJF Restricted Stock Unit represents a contingent right to receive one share of common stock plus accrued cash in lieu of dividends when the award vests. Vesting is tied to the next annual shareholders meeting, subject to the stated latest possible vesting date.

Does this Raymond James Form 4 show any stock sales by the director?

The Form 4 reports only equity grant, vesting, and conversion transactions, with no open-market stock sales. Activity includes a new RSU award and the conversion of vested RSUs into common shares at a price of $0.00 per share.